Home/ Stocks/ CYCN

Cyclerion Therapeutics, Inc. Common Stock

CYCN XNAS

$3.83 -0.09 (-2.29%) ▼ 15-min delayed

Open

$3.85

High

$3.85

Low

$3.51

Volume

27.6K

Market Cap

$16.61M

About Cyclerion Therapeutics, Inc. Common Stock

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-3,177,000	$-0.76
FY 2025	$2.07M	$-3,528,000	$-1.11
Q3 2025	$875.0K	$-976,000	$-0.30
Q2 2025	$93.0K	$-324,000	$-0.11

TickerDaily Coverage

Stock Market Today, April 3, 2026: Weekly Recap of Explosive Penny Stock Moves

Market News David Brooks · Apr 3, 2026

Friday, April 3, 2026 marked the close of a volatile week dominated by biotech and micro-cap...

Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 320.3% Today?

Market News Alex Chen · Apr 1, 2026

Cyclerion Therapeutics (CYCN) exploded higher Wednesday, gaining 320.3% to $6.49 on unprecedented...

Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 253.5% Today?

Penny Stocks Marcus Rivera · Apr 1, 2026

Cyclerion Therapeutics (CYCN) exploded 253.5% Wednesday, April 1, 2026, closing at $5.43 after...

View All Coverage →

Get CYCN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cyclerion Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.